ERBB2 and breast carcinoma: Gallen International Breast Cancer Consensus Conference redefined breast cancer molecular typing, dividing breast cancer into four subtypes: luminal A, luminal B, HER2-positive, and basal-like or triple-negative (TNBC) phenotype (28, 29).